Most of us treat our body fat like a singular, annoying entity. However, your body actually stores fat in different ways, and some types are much harder on your health than others.
When standard lifestyle changes need backup, researchers look at peptides to nudge your internal systems. Here is a look at what the current data says about managing weight and fat distribution.
The Heavy Hitters in Weight Management
You have likely heard people talking about new options for significant weight loss. One of the top-rated tools currently available is Tirzepatide.
This is what scientists call a dual agonist. In plain English, it acts like two different hormones in your body at the same time: GIP and GLP-1. By hitting both of these targets, it creates a team effort in your system.
According to the data, here is what it does:
- Appetite Control: It provides profound suppression of your appetite.
- Fat Processing: It improves fat oxidation, which is just a fancy way of saying it helps your body burn fat for energy.
- Proven Results: In a major study called SURMOUNT-1, people saw a 22.5% loss in body weight.
It is currently FDA-Approved under the names Zepbound and Mounjaro. While it is highly effective, scientists are still waiting on long-term heart health data and are looking for better ways to make sure people keep their muscle while losing weight.
Targeting the Dangerous Fat
Sometimes the goal isn't just a lower number on the scale, but moving fat away from your internal organs. This deep belly fat is called visceral adipose tissue (VAT).
Tesamorelin is a synthetic version of a hormone that tells your brain to release its own growth hormone. Unlike other options, it works through your body's natural cycle rather than bypassing it.
Here is why it is used:
- Internal Fat Reduction: Studies showed an 18% reduction in visceral fat and a 37% drop in liver fat.
- Specific Use: It is currently FDA-Approved specifically for lipodystrophy (an unusual fat distribution condition) in patients with HIV.
One thing to keep in mind: the data shows that if you stop using it, the effects reverse. Also, using it for general fat loss is considered "off-label," meaning it hasn't been through the final round of testing for the general public yet.
What About the Old Favorites?
You might come across AOD-9604. It was designed to trigger lipolysis (breaking down fat) without messing with your blood sugar or insulin.
However, the story here is a bit of a letdown. While early tests looked good, it failed its major Phase IIb trial (a late-stage study to prove it actually works) and clinical development stopped in 2007. Scientists are still working on this one—turns out the human body is complicated. Who knew?
This is a great one to bring up with your doctor. You can find peptide-experienced physicians in our Find a Doctor directory.
This content is sourced exclusively from TruthTides clinical reference data and does not constitute medical advice.
Referenced Peptides
This content was generated from TruthTides clinical reference data. It does not constitute medical advice. Always consult a qualified healthcare provider.